{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:42:10Z","timestamp":1785775330807,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T00:00:00Z","timestamp":1343692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s12022-012-9219-6","type":"journal-article","created":{"date-parts":[[2012,7,30]],"date-time":"2012-07-30T16:19:50Z","timestamp":1343665190000},"page":"254-259","source":"Crossref","is-referenced-by-count":10,"title":["Villous Papillary Thyroid Carcinoma: a Variant Associated with Marfan Syndrome"],"prefix":"10.1007","volume":"23","author":[{"given":"Daniel A.","family":"Winer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Winer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorne","family":"Rotstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia L.","family":"Asa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,31]]},"reference":[{"key":"9219_CR1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.2005.039669","volume":"43","author":"PN Robinson","year":"2006","unstructured":"Robinson PN, Arteaga-Solis E, Baldock C, Collod-B\u00e9roud G, Booms P, De Paepe A, Dietz HC, Guo G, Handford PA, Judge DP, Kielty CM, Loeys B, Milewicz DM, Ney A, Ramirez F, Reinhardt DP, Tiedemann K, Whiteman P, Godfrey M. The molecular genetics of Marfan syndrome and related disorders. J Med Genet 43:769\u2013787, 2006.","journal-title":"J Med Genet"},{"key":"9219_CR2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0022-5347(17)41492-3","volume":"140","author":"FH Dexeus","year":"1988","unstructured":"Dexeus FH, Logothetis CJ, Chong C, Sella A, Ogden S. Genetic abnormalities in men with germ cell tumors. J Urol 140:80\u201384, 1988.","journal-title":"J Urol"},{"key":"9219_CR3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clon.2004.06.028","volume":"17","author":"M Finlay","year":"2005","unstructured":"Finlay M, Laperriere N, Bristow RG. Radiotherapy and Marfan syndrome: a report of two cases. Clin Oncol (R Coll Radiol) 17:54\u201356, 2005.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"9219_CR4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0022-3468(82)80453-3","volume":"17","author":"SG Newbold","year":"1982","unstructured":"Newbold SG, Shafer AD, Goodwin CD., Nanagas VN, and Dimlich SH. Stage III Wilms\u2019 tumor of a solitary kidney in a patient with Marfan\u2019s syndrome: A 5-yr survival. J Pediatr Surg 17:841\u2013842, 1982.","journal-title":"J Pediatr Surg"},{"key":"9219_CR5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00277-003-0669-2","volume":"82","author":"DM Kraemer","year":"2003","unstructured":"Kraemer DM, Waschke J, Kunzmann V, Wilhelm M. Veno-occlusive disease in a male patient with Marfan syndrome and common acute lymphoblastic leukemia during induction therapy. Ann Hematol 82:444\u2013447, 2003.","journal-title":"Ann Hematol"},{"key":"9219_CR6","first-page":"23","volume":"40","author":"HL Gruber","year":"1963","unstructured":"Gruber HL, Samuel J. Hamartoma of the heart and carcinoma of the tongue associated with Marfan\u2019s syndrome. J Indian Med Assoc 40:23\u201328, 1963.","journal-title":"J Indian Med Assoc"},{"key":"9219_CR7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/03008207.2010.500430","volume":"52","author":"A Roopnariane","year":"2011","unstructured":"Roopnariane A, Freed RJ, Price S, Fox EJ, Ritty TM. Osteosarcoma in a Marfan patient with a novel premature termination codon in the FBN1 gene. Connect Tissue Res 52:157\u2013165, 2011.","journal-title":"Connect Tissue Res"},{"key":"9219_CR8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrc1836","volume":"6","author":"T Kondo","year":"2006","unstructured":"Kondo T, Ezzat S, Asa SL Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6:292\u2013306, 2006.","journal-title":"Nat Rev Cancer"},{"key":"9219_CR9","unstructured":"Howlader N NA, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (eds). SEER Cancer Statistics Review, 1975\u20132008, National Cancer Institute. Bethesda, MD, http:\/\/seer.cancer.gov\/csr\/1975_2008\/ , based on November 2010 SEER data submission, posted to the SEER web site, 2011."},{"key":"9219_CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12022-010-9106-y","volume":"21","author":"VA LiVolsi","year":"2010","unstructured":"LiVolsi VA. Papillary carcinoma tall cell variant (TCV): a review. Endocr Pathol 21:12\u201315, 2010.","journal-title":"Endocr Pathol"},{"key":"9219_CR11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0002-9440(10)64577-4","volume":"157","author":"KM Perle La","year":"2000","unstructured":"La Perle KM, Jhiang SM, Capen CC Loss of p53 promotes anaplasia and local invasion in ret\/PTC1-induced thyroid carcinomas. Am J Pathol 157:671\u2013677, 2000.","journal-title":"Am J Pathol"},{"key":"9219_CR12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02739704","volume":"8","author":"SA Hosal","year":"1997","unstructured":"Hosal SA, Apel RL, Freeman JL, Azadian A, Rosen IB, LiVolsi VA, Asa SL. Immunohistochemical Localization of p53 in Human Thyroid Neoplasms: Correlation with Biological Behavior. Endocr Pathol 8:21\u201328, 1997.","journal-title":"Endocr Pathol"},{"key":"9219_CR13","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1210\/jc.87.4.1810","volume":"87","author":"ML Khoo","year":"2002","unstructured":"Khoo ML, Ezzat S, Freeman JL, Asa SL Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification. J Clin Endocrinol Metab 87:1810\u20131813, 2002.","journal-title":"J Clin Endocrinol Metab"},{"key":"9219_CR14","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1210\/jc.87.4.1814","volume":"87","author":"ML Khoo","year":"2002","unstructured":"Khoo ML, Beasley NJ, Ezzat S, Freeman JL, Asa SL. Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma. J Clin Endocrinol Metab 87:1814\u20131818, 2002.","journal-title":"J Clin Endocrinol Metab"},{"key":"9219_CR15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1001\/archotol.128.3.253","volume":"128","author":"ML Khoo","year":"2002","unstructured":"Khoo ML, Freeman JL, Witterick IJ, Irish JC, Rotstein LE, Gullane PJ, Asa SL. Underexpression of p27\/Kip in thyroid papillary microcarcinomas with gross metastatic disease. Arch Otolaryngol Head Neck Surg 128:253\u2013257, 2002.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"9219_CR16","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1158\/1078-0432.CCR-10-2837","volume":"17","author":"S Cheng","year":"2011","unstructured":"Cheng S, Serra S, Mercado M, Ezzat S, Asa SL 2011 A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior. Clin Cancer Res 17:2385\u20132394, 2011.","journal-title":"Clin Cancer Res"},{"key":"9219_CR17","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1073\/pnas.0610733104","volume":"104","author":"V Vasko","year":"2007","unstructured":"Vasko V, Espinosa AV, Scouten W, He H, Auer H, Liyanarachchi S, Larin A, Savchenko V, Francis GL, de la Chapelle A, Saji M, Ringel MD. Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci U S A 104:2803\u20132808, 2007.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9219_CR18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2045-3701-1-29","volume":"1","author":"Y Jing","year":"2011","unstructured":"Jing Y, Han Z, Zhang S, Liu Y, Wei L. Epithelial-Mesenchymal Transition in tumor microenvironment. Cell Biosci 1:29, 2011.","journal-title":"Cell Biosci"},{"key":"9219_CR19","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/modpathol.2011.119","volume":"24","author":"O Mete","year":"2011","unstructured":"Mete O, Asa SL. Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol 24:1545\u20131552, 2011.","journal-title":"Mod Pathol"},{"key":"9219_CR20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2853","volume":"10","author":"H Ikushima","year":"2010","unstructured":"Ikushima H, Miyazono K TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer 10:415\u2013424, 2010.","journal-title":"Nat Rev Cancer"},{"key":"9219_CR21","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1210\/jc.2008-0607","volume":"93","author":"R Elisei","year":"2008","unstructured":"Elisei R, Ugolini C, Viola D, Lupi C, Biagini A, Giannini R, Romei C, Miccoli P, Pinchera A, Basolo F. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab 93:3943\u20133949, 2008.","journal-title":"J Clin Endocrinol Metab"},{"key":"9219_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10038-006-0078-1","volume":"52","author":"T Mizuguchi","year":"2007","unstructured":"Mizuguchi T, Matsumoto N. Recent progress in genetics of Marfan syndrome and Marfan-associated disorders. J Hum Genet 52:1\u201312, 2007.","journal-title":"J Hum Genet"},{"key":"9219_CR23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ng1392","volume":"36","author":"T Mizuguchi","year":"2007","unstructured":"Mizuguchi T, Collod-Beroud G, Akiyama T, Abifadel M, Harada N, Morisaki T, Allard D, Varret M, Claustres M, Morisaki H, Ihara M, Kinoshita A, Yoshiura K, Junien C, Kajii T, Jondeau G, Ohta T, Kishino T, Furukawa Y, Nakamura Y, Niikawa N, Boileau C, Matsumoto N. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet 36:855\u2013860, 2007.","journal-title":"Nat Genet"},{"key":"9219_CR24","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1038\/onc.2011.44","volume":"30","author":"JA Knauf","year":"2011","unstructured":"Knauf JA, Sartor MA, Medvedovic M, Lundsmith E, Ryder M, Salzano M, Nikiforov YE, Giordano TJ, Ghossein RA, Fagin JA. Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFbeta signaling. Oncogene 30:3153\u20133162, 2011.","journal-title":"Oncogene"},{"key":"9219_CR25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mce.2009.10.012","volume":"321","author":"M Xing","year":"2010","unstructured":"Xing M. Prognostic utility of BRAF mutation in papillary thyroid cancer. Mol Cell Endocrinol 321:86\u201393, 2010.","journal-title":"Mol Cell Endocrinol"},{"key":"9219_CR26","doi-asserted-by":"crossref","first-page":"8317","DOI":"10.1158\/0008-5472.CAN-09-1248","volume":"69","author":"G Riesco-Eizaguirre","year":"2009","unstructured":"Riesco-Eizaguirre G, Rodriguez I, De la Vieja A, Costamagna E, Carrasco N, Nistal M, Santisteban P. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Cancer Res 69:8317\u20138325, 2009.","journal-title":"Cancer Res"},{"key":"9219_CR27","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1101\/gad.181700","volume":"14","author":"K Lehmann","year":"2000","unstructured":"Lehmann K, Janda E, Pierreux CE, Rytomaa M, Schulze A, McMahon M, Hill CS, Beug H, Downward J. Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev 14:2610\u20132622, 2000.","journal-title":"Genes Dev"},{"key":"9219_CR28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1083\/jcb.200109037","volume":"156","author":"E Janda","year":"2002","unstructured":"Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, Beug H, Grunert S. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 156:299\u2013313, 2002.","journal-title":"J Cell Biol"},{"key":"9219_CR29","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1245\/s10434-011-1733-0","volume":"18","author":"L Yip","year":"2011","unstructured":"Yip L, Kelly L, Shuai Y, Armstrong MJ, Nikiforov YE, Carty SE, Nikiforova MN. MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. Ann Surg Oncol 18:2035\u20132041, 2011.","journal-title":"Ann Surg Oncol"},{"key":"9219_CR30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12022-008-9045-z","volume":"19","author":"V Nose","year":"2008","unstructured":"Nose V. Familial non-medullary thyroid carcinoma: an update. Endocr Pathol 19:226\u2013240, 2008.","journal-title":"Endocr Pathol"},{"key":"9219_CR31","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1073\/pnas.0703056104","volume":"104","author":"G Gasparre","year":"2007","unstructured":"Gasparre G, Porcelli AM, Bonora E, Pennisi LF, Toller M, Iommarini L, Ghelli A, Moretti M, Betts CM, Martinelli GN, Ceroni AR, Curcio F, Carelli V, Rugolo M, Tallini G, Romeo G. Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors. Proc Natl Acad Sci U S A 104:9001\u20139006, 2007.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9219_CR32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12022-009-9102-2","volume":"21","author":"O Mete","year":"2010","unstructured":"Mete O, Asa SL. Oncocytes, oxyphils, Hurthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules. Endocr Pathol 21:16\u201324, 2010.","journal-title":"Endocr Pathol"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-012-9219-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-012-9219-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-012-9219-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T04:55:56Z","timestamp":1562043356000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-012-9219-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,31]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["9219"],"URL":"https:\/\/doi.org\/10.1007\/s12022-012-9219-6","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,31]]}}}